Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Past Articles
Letters to the Editor: What About Biomarkers for Parkinson’s Disease?
Dear Editor: Parkinson’s disease (PD) affects over 600,000 patients in the United States; these numbers might double by 2040, as the population of older people increases.1 Diagnostic clues include the signs of resting tremor, bradykinesia, [...]
Longitudinal Data in Patients with Niemann-Pick Type C Disease Under Combined High Intrathecal and Low Intravenous Dose of 2-hydroxylpropyl-β-cyclodextrin
by Evangelia Bountouvi, MD, PhD; Melpomeni Giorgi, MD; Anna Papadopoulou, PhD; Kaj Blennow, PhD; Ingemar Björkhem, PhD; Maria Tsirouda, PhD; Spyridon Kanellakis, Msc, PhD; Andreas Fryganas, MD; Maria Spanou, MD; Ioanna Georgaki, MD; Sofia Asprogeraka, [...]
Catatonia in a 6-year-old Patient Following Disseminated Group A Streptococcus Infection
by Philip B Cawkwell, MD; Ivan Daniel Mayor, BA; and Richard J. Shaw,MD Drs. Cawkwell and Shaw and Mr. Mayor are with the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, [...]
Blood–Brain Barrier: COVID-19, Pandemics, and Cytokine Norms
by Atmaram Yarlagadda, MD; Samuel L. Preston, DO; Rachel P. Jeyadhas, MD; Adam Edward Lang, PharmD; Rasha Hammamieh, PhD; And Anita H. Clayton, MD Dr. Yarlagadda is the Installation Director of Psychological Health at McDonald [...]
Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments
by Philip D. Harvey, PhD; Michelle L. Miller, MS; Raeanne C. Moore, PhD; Colin A. Depp, PhD; Emma M. Parrish, BS; and Amy E. Pinkham, PhD Dr. Harvey is with the University of Miami Miller [...]
Integration of Advanced Health Technology Within the Healthcare System to Fight the Global Pandemic: Current Challenges and Future Opportunities
by Tarneem Darwish, MD; Samuel Korouri, BA; Mia Pasini, RN, MSN; Maria Veronica Cortez, RN; and Waguih William IsHak, MD, FAPA Drs. Darwish and IsHak and Mr. Korouri, Ms. Pasini, and Ms. Cortez are with [...]
Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic
by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with Sorantin Outcomes, LLC, in Mountain [...]
Effects of Prismatic Lenses on Lateral Axial Dystonia in Parkinson’s Disease: A Pilot Study
by Michele Meglio, PhD Student; Enrica Olivola, MD, PhD; Marco Santilli, BSC; Francesco Lena, MSC, PhD; Diego Centonze, MD, PhD; Matteo Bologna, MD, PhD; and Nicola Modugno, MD, PhD Dr. Meglio is with IRCCS Neuromed [...]